首页> 外文期刊>Drug development and industrial pharmacy >Microemulsions as transdermal drug delivery systems for nonsteroidal anti-inflammatory drugs (NSAIDs): a literature review
【24h】

Microemulsions as transdermal drug delivery systems for nonsteroidal anti-inflammatory drugs (NSAIDs): a literature review

机译:微乳液作为非甾体抗炎药物透皮药物递送系统(NSAIDS):文献综述

获取原文
获取原文并翻译 | 示例
           

摘要

Pain is a global crisis and significant efforts have gone into the development of drugs that can be used to treat pain. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of analgesics that act to selectively relieve pain and inflammation without significantly altering consciousness. Although there have been many advancements with NSAIDs drug development; these drugs still present with severe adverse effects and toxicities, which often limits their use in many patients. Moreover, others are inadequate in relieving specific types of pain such as localized or nerve pain because of poor systemic absorption with conventional delivery systems. The topical route of drug delivery has been used to avoid many of these effects, but not without challenges of its own. The skin acts as an impermeable barrier to most polar drug candidate and absorption across the dermal membranes is often too slow and incomplete to produce meaningful therapeutic benefit. Nevertheless, the use of microemulsions as topical delivery systems for small molecule drug candidates like NSAIDs has been posited as a solution to this problem for years. This review focuses on the recent use of microemulsions as a probable solution to the challenges of transdermal drug delivery of NSAIDs and how microemulsions may be used to enhance the development of more effective but safer analgesic drug products for patients.
机译:疼痛是全球危机,重大努力已经进入可用于治疗疼痛的药物的发展。非甾体类抗炎药(NSAIDs)是一类镇痛药,其行为,以选择性地缓解疼痛和炎症,而不会显着改变意识。虽然NSAIDS药物开发出现了许多进步;这些药物仍存在严重的不良反应和毒性,这通常会限制它们在许多患者中的使用。此外,由于与传统递送系统的全身吸收不良,其他人在缓解特定类型的疼痛时不足以减轻局部或神经疼痛。药物递送的局部途径已被用来避免许多这些影响,但并非没有自己的挑战。皮肤作为对大多数极地药物候选物的不可渗透屏障,并且在皮肤膜上的吸收通常过于缓慢和不完整,以产生有意义的治疗益处。然而,使用微乳液作为用于小分子药物候选物的局部递送系统,如NSAIDS,多年来一直被列为对此问题的解决方案。本综述重点是最近使用微乳液作为NSAIDs的透皮药物递送的挑战以及如何使用微乳液来增强患者更有效但更安全的镇痛药物的发育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号